Bienville Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$178K	Hold	58,053	–	–	0.03%	72
2025 Q4	$237K	Hold	58,053	–	–	0.04%	71
2025 Q3	$283K	Hold	58,053	–	–	0.05%	64
2025 Q2	$294K	Hold	58,053	–	–	0.06%	60
2025 Q1	$307K	Hold	58,053	–	–	0.07%	57
2024 Q4	$392K	Hold	58,053	–	–	0.1%	66
2024 Q3	$383K	Hold	58,053	–	–	0.1%	64
2024 Q2	$435K	Hold	58,053	–	–	0.1%	61
2024 Q1	$579K	Hold	58,053	–	–	0.18%	55
2023 Q4	$572K	Hold	58,053	–	–	0.17%	61
2023 Q3	$444K	Buy	58,053 +1,177	+2%	+$11.7K	0.14%	64
2023 Q2	$425K	Hold	56,876	–	–	0.16%	61
2023 Q1	$379K	Hold	56,876	–	–	0.15%	69
2022 Q4	$439K	Sell	56,876 -4,062	-7%	-$39.8K	0.16%	61
2022 Q3	$648K	Buy	60,938 +24,375	+67%	+$247K	0.25%	50
2022 Q2	$298K	Hold	36,563	–	–	0.14%	103
2022 Q1	$262K	Hold	36,563	–	–	0.13%	120
2021 Q4	$626K	Buy	+36,563	New	+$688K	0.45%	44